Takeda collaboration to optimise biopharmaceutical manufacturing announced
June 22, 2021Manufacturing and Production Takeda, collaboration, manufacturing
A 36-month joint project between Takeda’s manufacturing site in Vienna, the Research Center Pharmaceutical Engineering (RCPE), InSilicoTrials, and the University …
LegoChem and Iksuda expand License Agreement for antibody drug conjugates
June 22, 2021Manufacturing and Production ADC, License Agreement, deal, technology
Iksuda Therapeutics, a developer of antibody drug conjugates (ADCs), has announced the expansion of the research collaboration and License Agreement …
Insect-based vaccine production platform validated by EMA
June 22, 2021Manufacturing and Production Insect-based, Vaccine, production, technology
Algenex SL has announced EMA validation of a recombinant subunit vaccine produced by their baculovirus vector-mediated expression platform, that harnesses …
GSK’s ViiV and Halozyme to collaborate on ‘ultra-long acting’ HIV drugs
June 22, 2021Manufacturing and Production GSK, HIV, ViiV Healthcare
ViiV Healthcare, the specialist HIV company majority owned by GlaxoSmithKline (GSK), is to collaborate with Halozyme Therapeutics, giving it exclusive …
AstraZeneca ordered to deliver 50 million vaccine doses to EU
June 21, 2021Sales and Marketing
A Belgian court has instructed AstraZeneca to deliver 50 million COVID-19 shots to the European Union following a dispute on …
EU approves Onureg for patients with acute myeloid leukemia
June 21, 2021Sales and Marketing
The European Commission has approved Onureg as frontline oral maintenance therapy for patients with a broad range of acute myeloid …
Alzheimer’s drug approval: Advocacy group calls for FDA resignations
June 21, 2021Sales and Marketing
Public Citizen, the US consumer advocacy group, has called for the resignation of three top FDA officials following the approval …
Novartis’s Zolgensma for SMA shows ‘extraordinary’ results
June 21, 2021Sales and Marketing
New late-breaker data from the Phase III trial for Zolgensma, the world’s most expensive drug, has shown positive results. Zolgensma …
EU approves Aubagio for children living with MS
June 21, 2021Sales and Marketing
The EU has approved Aubagio (teriflunomide) for the treatment of paediatric patients 10 to 17 years of age with relapsing-remitting …
Breakthrough announced in circulating tumour cell research
June 18, 2021Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology
Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …
UK AI firm wins share of £140 million funding for lung cancer detection tech
June 18, 2021Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology
Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …
Australia pauses AstraZeneca vaccine for people under 60
June 18, 2021Medical Communications AstraZeneca, Australia, COVID-19, Vaccine
Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …
New class of cancer-killing drugs identified
June 18, 2021Medical Communications Cancer, oncology
Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …
NICE recommends two new treatments for inflammatory arthritis
June 18, 2021Medical Communications Eli Lilly, NICE, Novartis
NICE has recommended two new treatments for axial spondyloarthritis, an underdiagnosed and debilitating type of inflammatory arthritis. Ixekizumab (also known …
Prostate cancer detection system wins government funding
June 17, 2021A prostate cancer detection software system, to help pathologists quickly identify suspicious areas of tissue, has won government funding. The …
NHS to pilot artificial pancreas for type 1 diabetes
June 17, 2021NHS, diabetes, insulin, technology, wearable technology
The NHS has announced that artificial pancreases will be available to patients with type 1 diabetes, with up to 1,000 …
Biogen’s Phase II Alzheimer’s study misses primary endpoint
June 17, 2021Biogen’s Phase II study for gosuranemab, an anti-tau antibody for Alzheimer’s disease, did not meet its primary endpoint, and has …
Epilepsy drug receives MHRA marketing authorisation
June 17, 2021MHRA, epilepsy, marketing authorisation
The MHRA has granted marketing authorisation (MA) for Ontozry (cenobamate) for the treatment of focal-onset seizures in adult patients with …
UK COVID vaccine update
June 16, 2021Research and Development COVID-19, UK, care homes, children, government, vaccines
Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
